AbbVie Inc. is 66.2x more valuable than PTC THERAPEUTICS, INC. by market capitalization ($399.47 B vs $6.03 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | PTCT | ABBV |
|---|---|---|
| Market cap | $6.03 B | $399.47 B |
| US-listed rank | #1262 | #28 |
| Revenue (latest FY) | $1.73B | $61.16B |
| Net income (latest FY) | $683.00M | $4.23B |
| Net margin | 39.5% | 6.9% |
| P/E (trailing FY) | 8.8 | 94.5 |
| SEC filings | 1,262 | 1,008 |
AbbVie Inc. is 66.2x more valuable than PTC THERAPEUTICS, INC. by market capitalization ($399.47 B vs $6.03 B).
In their latest fiscal years, PTC THERAPEUTICS, INC. reported $1.73B in revenue while AbbVie Inc. reported $61.16B.
Full pages: PTC THERAPEUTICS, INC. and AbbVie Inc., or browse the full rankings.